Shares in Misys were down on the FTSE 250 in afternoon trading, ahead of the financial services software company's half year results, expected tomorrow.
Last year saw the company refocus itself on its core business. The group sold its healthcare software business, using the proceeds to help fund a share buyback programme, before acquiring Irish capital markets software provider Sophis.
Keith Bowman, analyst at Hargreaves Lansdown, said, "The coming half-year results are expected to see management reporting on early efforts to integrate Sophis. Ahead of the results, market consensus opinion currently denotes a buy."
By 14:50 shares in Misys were down 1.80 per cent on the FTSE 250 to 333.60 pence per share.